Advocate Investing Services’s Bio-Techne TECH Stock Holding History

Advocate Investing Services’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24	Closed	-$1.25K	–	482
2026 Q1	$1.25K	Hold	24	–	–	﹤0.01%	392
2025 Q4	$1.41K	Buy	+24	New	+$1.46K	﹤0.01%	369

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Advocate Investing Services's TECH Position: Q2 2026 in Review

Advocate Investing Services sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 24 shares — an estimated $1.25K sold.

Advocate Investing Services first reported a position in TECH in Q4 2025 and held it in 2 quarters. The position peaked at $1.41K in Q4 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Advocate Investing Services reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
Advocate Investing Services sold 24 Bio-Techne shares in Q2 2026, an estimated $1.25K.
Advocate Investing Services first reported a position in Bio-Techne in Q4 2025 and held it in 2 quarters.
Advocate Investing Services's Bio-Techne position peaked at $1.41K in Q4 2025.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Advocate Investing Services's 13F filing for Q2 2026, filed 29 Jul 2026.